Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma

Haskell Kirkpatrick, Pamela Waber, To Hoa-Thai, Robert Barnes, Sherri Osborne-Lawrence, John Truelson, Perry Nisen, Anne Bowcock

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Alterations of BRCA2, result in increased susceptibility to breast cancer in both men and women (relative lifetime risks of 0.06 and 0.8 respectively). BRCA2 maps to 13q12-q13 and encodes a transcript of 10 157 bp. Other cancers that have been described in BRCA2 mutation carriers include those of the larynx. Human chromosome 13q has been shown previously by LOH studies to harbor several tumor suppressor genes for head and neck squamous cell carcinoma (HNSCCs). We therefore examined the role of BRCA2 in the development of these cancers. Only 6/22 (27%) of the laryngeal cancers we examined demonstrated LOH of the BRCA2-containing region. These and 10 other HNSCCs of different origins that were demonstrated by LOH studies to have lost the region of chromosome 13 containing BRCA2 were examined for alterations in this gene. SSCP analysis failed to reveal any alterations leading us to conclude that BRCA2 alterations are not frequently involved in the pathogenesis of HNSCCs and that the observed LOH of chromosome 13 loci is due to other, as yet, unidentified tumor suppressor gene(s). Interestingly tumors with LOH in this region (proximal to D13S118) were far more likely to be derived from women than men. This is unusual since HNSCCs are usually fourfold more common in men than in women.

Original languageEnglish (US)
Pages (from-to)2189-2193
Number of pages5
JournalOncogene
Volume14
Issue number18
StatePublished - 1997

Fingerprint

Chromosomes, Human, Pair 13
Tumor Suppressor Genes
Single-Stranded Conformational Polymorphism
Neoplasms
Laryngeal Neoplasms
Human Chromosomes
Larynx
Breast Neoplasms
Mutation
Carcinoma, squamous cell of head and neck
Genes

Keywords

  • BRCA2
  • Chromosome 13
  • Head and neck squamous cell carcinoma
  • Mutational analysis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Kirkpatrick, H., Waber, P., Hoa-Thai, T., Barnes, R., Osborne-Lawrence, S., Truelson, J., ... Bowcock, A. (1997). Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. Oncogene, 14(18), 2189-2193.

Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. / Kirkpatrick, Haskell; Waber, Pamela; Hoa-Thai, To; Barnes, Robert; Osborne-Lawrence, Sherri; Truelson, John; Nisen, Perry; Bowcock, Anne.

In: Oncogene, Vol. 14, No. 18, 1997, p. 2189-2193.

Research output: Contribution to journalArticle

Kirkpatrick, H, Waber, P, Hoa-Thai, T, Barnes, R, Osborne-Lawrence, S, Truelson, J, Nisen, P & Bowcock, A 1997, 'Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma', Oncogene, vol. 14, no. 18, pp. 2189-2193.
Kirkpatrick H, Waber P, Hoa-Thai T, Barnes R, Osborne-Lawrence S, Truelson J et al. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. Oncogene. 1997;14(18):2189-2193.
Kirkpatrick, Haskell ; Waber, Pamela ; Hoa-Thai, To ; Barnes, Robert ; Osborne-Lawrence, Sherri ; Truelson, John ; Nisen, Perry ; Bowcock, Anne. / Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. In: Oncogene. 1997 ; Vol. 14, No. 18. pp. 2189-2193.
@article{8ba1cf800f30437b935148947cc8afa2,
title = "Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma",
abstract = "Alterations of BRCA2, result in increased susceptibility to breast cancer in both men and women (relative lifetime risks of 0.06 and 0.8 respectively). BRCA2 maps to 13q12-q13 and encodes a transcript of 10 157 bp. Other cancers that have been described in BRCA2 mutation carriers include those of the larynx. Human chromosome 13q has been shown previously by LOH studies to harbor several tumor suppressor genes for head and neck squamous cell carcinoma (HNSCCs). We therefore examined the role of BRCA2 in the development of these cancers. Only 6/22 (27{\%}) of the laryngeal cancers we examined demonstrated LOH of the BRCA2-containing region. These and 10 other HNSCCs of different origins that were demonstrated by LOH studies to have lost the region of chromosome 13 containing BRCA2 were examined for alterations in this gene. SSCP analysis failed to reveal any alterations leading us to conclude that BRCA2 alterations are not frequently involved in the pathogenesis of HNSCCs and that the observed LOH of chromosome 13 loci is due to other, as yet, unidentified tumor suppressor gene(s). Interestingly tumors with LOH in this region (proximal to D13S118) were far more likely to be derived from women than men. This is unusual since HNSCCs are usually fourfold more common in men than in women.",
keywords = "BRCA2, Chromosome 13, Head and neck squamous cell carcinoma, Mutational analysis",
author = "Haskell Kirkpatrick and Pamela Waber and To Hoa-Thai and Robert Barnes and Sherri Osborne-Lawrence and John Truelson and Perry Nisen and Anne Bowcock",
year = "1997",
language = "English (US)",
volume = "14",
pages = "2189--2193",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "18",

}

TY - JOUR

T1 - Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma

AU - Kirkpatrick, Haskell

AU - Waber, Pamela

AU - Hoa-Thai, To

AU - Barnes, Robert

AU - Osborne-Lawrence, Sherri

AU - Truelson, John

AU - Nisen, Perry

AU - Bowcock, Anne

PY - 1997

Y1 - 1997

N2 - Alterations of BRCA2, result in increased susceptibility to breast cancer in both men and women (relative lifetime risks of 0.06 and 0.8 respectively). BRCA2 maps to 13q12-q13 and encodes a transcript of 10 157 bp. Other cancers that have been described in BRCA2 mutation carriers include those of the larynx. Human chromosome 13q has been shown previously by LOH studies to harbor several tumor suppressor genes for head and neck squamous cell carcinoma (HNSCCs). We therefore examined the role of BRCA2 in the development of these cancers. Only 6/22 (27%) of the laryngeal cancers we examined demonstrated LOH of the BRCA2-containing region. These and 10 other HNSCCs of different origins that were demonstrated by LOH studies to have lost the region of chromosome 13 containing BRCA2 were examined for alterations in this gene. SSCP analysis failed to reveal any alterations leading us to conclude that BRCA2 alterations are not frequently involved in the pathogenesis of HNSCCs and that the observed LOH of chromosome 13 loci is due to other, as yet, unidentified tumor suppressor gene(s). Interestingly tumors with LOH in this region (proximal to D13S118) were far more likely to be derived from women than men. This is unusual since HNSCCs are usually fourfold more common in men than in women.

AB - Alterations of BRCA2, result in increased susceptibility to breast cancer in both men and women (relative lifetime risks of 0.06 and 0.8 respectively). BRCA2 maps to 13q12-q13 and encodes a transcript of 10 157 bp. Other cancers that have been described in BRCA2 mutation carriers include those of the larynx. Human chromosome 13q has been shown previously by LOH studies to harbor several tumor suppressor genes for head and neck squamous cell carcinoma (HNSCCs). We therefore examined the role of BRCA2 in the development of these cancers. Only 6/22 (27%) of the laryngeal cancers we examined demonstrated LOH of the BRCA2-containing region. These and 10 other HNSCCs of different origins that were demonstrated by LOH studies to have lost the region of chromosome 13 containing BRCA2 were examined for alterations in this gene. SSCP analysis failed to reveal any alterations leading us to conclude that BRCA2 alterations are not frequently involved in the pathogenesis of HNSCCs and that the observed LOH of chromosome 13 loci is due to other, as yet, unidentified tumor suppressor gene(s). Interestingly tumors with LOH in this region (proximal to D13S118) were far more likely to be derived from women than men. This is unusual since HNSCCs are usually fourfold more common in men than in women.

KW - BRCA2

KW - Chromosome 13

KW - Head and neck squamous cell carcinoma

KW - Mutational analysis

UR - http://www.scopus.com/inward/record.url?scp=0030914404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030914404&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 2189

EP - 2193

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 18

ER -